{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:28:38Z","timestamp":1789986518169,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clnu.2025.02.017","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:32:03Z","timestamp":1739896323000},"page":"136-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A fasting-mimicking diet programme reduces liver fat and liver inflammation\/fibrosis measured by magnetic resonance imaging in patients with type 2 diabetes"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-5304","authenticated-orcid":false,"given":"Elske L.","family":"van den Burg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-4190","authenticated-orcid":false,"given":"Marjolein P.","family":"Schoonakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7963-6575","authenticated-orcid":false,"given":"Petra G.","family":"van Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-4923","authenticated-orcid":false,"given":"Saskia","family":"le Cessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-5426","authenticated-orcid":false,"given":"Mattijs E.","family":"Numans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3076-1551","authenticated-orcid":false,"given":"Hanno","family":"Pijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6969-2418","authenticated-orcid":false,"given":"Hildo J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnu.2025.02.017_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The relationship between type 2 diabetes, NAFLD, and cardiovascular risk","volume":"21","author":"Caussy","year":"2021","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.clnu.2025.02.017_bib2","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J\u00a0Diabetes Res"},{"issue":"6","key":"10.1016\/j.clnu.2025.02.017_bib3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.clnu.2025.02.017_bib5","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.numecd.2023.08.008","article-title":"Prevalence of non-alcoholic fatty liver in the general Dutch population and in groups at increased risk","volume":"33","author":"Alblas","year":"2023","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2025.02.017_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.clnu.2025.02.017_bib8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clnu.2025.02.017_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.clnu.2025.02.017_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MEG.0000000000001075","article-title":"Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis","volume":"30","author":"Zhou","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2025.02.017_bib11","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.clnu.2025.02.017_bib12","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.clnu.2025.02.017_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr"},{"issue":"21","key":"10.1016\/j.clnu.2025.02.017_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214655","article-title":"The role of intermittent fasting in the management of nonalcoholic fatty liver disease: a narrative review","volume":"14","author":"Lavallee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2025.02.017_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.709683","article-title":"Effect of intermittent fasting on non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"8","author":"Yin","year":"2021","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2015.05.012","article-title":"A\u00a0periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan","volume":"22","author":"Brandhorst","year":"2015","journal-title":"Cell Metab"},{"issue":"377","key":"10.1016\/j.clnu.2025.02.017_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8700","article-title":"Fasting-mimicking diet and markers\/risk factors for aging, diabetes, cancer, and cardiovascular disease","volume":"9","author":"Wei","year":"2017","journal-title":"Sci Transl Med"},{"issue":"23","key":"10.1016\/j.clnu.2025.02.017_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202100381","article-title":"Improvement of non-alcoholic fatty liver disease in mice by intermittent use of a fasting-mimicking diet","volume":"65","author":"Zhao","year":"2021","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"10.1016\/j.clnu.2025.02.017_bib19","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00125-024-06137-0","article-title":"Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial","volume":"67","author":"van den Burg","year":"2024","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.clnu.2025.02.017_bib20","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jmri.27292","article-title":"Multiparametric MRI in patients with nonalcoholic fatty liver disease","volume":"53","author":"Schaapman","year":"2021","journal-title":"J\u00a0Magn Reson Imag"},{"key":"10.1016\/j.clnu.2025.02.017_bib21","article-title":"Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis","volume":"11","author":"Dennis","year":"2020","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","article-title":"Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease","volume":"60","author":"Banerjee","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2025.02.017_bib23","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31643","article-title":"T(1) mapping of the abdomen, from the AJR \"how we do it\" special series","author":"Serai","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.clnu.2025.02.017_bib24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","article-title":"Liver disease is a significant risk factor for cardiovascular outcomes - a UK Biobank study","volume":"79","author":"Roca-Fernandez","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12902-020-00576-7","article-title":"Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes","volume":"20","author":"van den Burg","year":"2020","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"10.1016\/j.clnu.2025.02.017_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214921","article-title":"Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver","volume":"14","author":"Bachtiar","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnu.2025.02.017_bib28","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.clnu.2025.02.017_bib29","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","article-title":"Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis","volume":"20","author":"Andersson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clnu.2025.02.017_bib30","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/liv.14625","article-title":"Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease","volume":"40","author":"Jayaswal","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.clnu.2025.02.017_bib31","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47763-8","article-title":"A\u00a0randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease","volume":"9","author":"Johari","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12876-019-1132-8","article-title":"Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial","volume":"19","author":"Cai","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnu.2025.02.017_bib34","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1530\/EC-20-0490","article-title":"Pathophysiology of NASH in endocrine diseases","volume":"10","author":"Gariani","year":"2021","journal-title":"Endocr Connect"},{"issue":"4","key":"10.1016\/j.clnu.2025.02.017_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.clnu.2025.02.017_bib36","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.clnu.2025.02.017_bib37","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"Sepp\u00e4l\u00e4-Lindroos","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clnu.2025.02.017_bib38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clnu.2025.02.017_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of \u2265 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.clnu.2025.02.017_bib40","doi-asserted-by":"crossref","first-page":"G329","DOI":"10.1152\/ajpgi.00044.2018","article-title":"Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis","volume":"315","author":"Hohenester","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.clnu.2025.02.017_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/KGJU3398","article-title":"Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review\u00a0and economic evaluation","volume":"27","author":"Bresnahan","year":"2023","journal-title":"Health Technol Assess"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T20:45:53Z","timestamp":1745527553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561425000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S0261561425000524"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2025.02.017","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fasting-mimicking diet programme reduces liver fat and liver inflammation\/fibrosis measured by magnetic resonance imaging in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2025.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}